SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022348
Filing Date
2017-11-07
Accepted
2017-11-07 17:27:50
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20170930.htm 10-Q 1758547
2 EX-31.1 xene-ex311_10.htm EX-31.1 18952
3 EX-31.2 xene-ex312_8.htm EX-31.2 19013
4 EX-32.1 xene-ex321_11.htm EX-32.1 11684
5 EX-32.2 xene-ex322_9.htm EX-32.2 11319
  Complete submission text file 0001564590-17-022348.txt   4130147

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xene-20170930.xml EX-101.INS 702691
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20170930.xsd EX-101.SCH 27649
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20170930_cal.xml EX-101.CAL 29109
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20170930_def.xml EX-101.DEF 45979
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20170930_lab.xml EX-101.LAB 189518
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20170930_pre.xml EX-101.PRE 134853
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 171184496
SIC: 2834 Pharmaceutical Preparations